PeterFOrioIIIDO

PubMed

• 33 citations
  Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.
  Nikhil G. Thaker, Thomas J. Pugh, Usama Mahmood, Seungtaek Choi, Tracy E. Spinks
  Brachytherapy. 2015-05-01
• 4 citations
  Remote surgical education using synthetic models combined with an augmented reality headset.
  Nelson N Stone, Michael P Wilson, Steven H Griffith, Jos Immerzeel, Frans Debruyne
  Surgery Open Science. 2022-10-01
• 2 citations
  Knowledge-based inverse treatment planning for low-dose-rate prostate brachytherapy.
  Christian V. Guthier, Peter F. Orio, Ivan Buzurovic, Robert A. Cormack
  Medical Physics. 2021-05-01

Journal Articles

• Determining Optimal Eluter Design by Modeling Physical Dose Enhancement in Brachytherapy  
  P F Orio, M T King, P L Nguyen, Medical Physics
• Incidence and Predictors of Upgrading and Upstaging Among 10,000 Contemporary Patients with Low-risk Prostate Cancer  
  Dinh KT, Mahal BA, Ziehr DR, Muralidhar V, Chen YW, Viswanathan VB, Nezolosky M, Beard CJ, Choueiri TK, Martin NE, Orio PF, Sweeney CJ, Trinh QD, Nguyen PL, J Urol, 1/10/2015
• Risk of prostate cancer mortality in men with a history of prior cancer  
  Dinh K, Mahal B, Ziehr D, Muralidhar V, Chen YW, Viswanathan V, Nezolosky M, Beard C, Choueiri T, Martin N, Orio PF, Sweeney C, Trinh Q, Nguyen, P, BJU Int, 1/4/2015
• Is Supplemental External beam Radiation Therapy Necessary for Patients with Higher Risk Prostate Cancer Treated with (103)Pd? Results of Two Prospective Randomized Trials  
  Merrick, GS, Wallner, K, Galbreath, RW, Butler, WM, Fiano, R, Orio, PF, Adamovich, E, Brachytherapy, 1/1/2015
• Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer  
  Dinh, KT, Mahal, BA, Ziehr, DR, Muralidhar, V, Chen, YW, Viswanathan, VB, Nezolosky, MD, Beard, CJ, Choueiri, TK, Martin, NE, Orio, PF, Sweeney, CJ, Trinh, QD, Nguyen, PL, J Urol, 1/1/2015
• Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer  
  Muralidhar P, Mahal B, Ziehr D, Chen YW, Nezolosky M, Viswanathan V, Beard C, Devlin P, Martin N, Orio PF, Nguyen PL, Brachytherapy, 1/1/2015
• A Review of Rectal Toxicity following Permanent Low-Dose Rate Prostate Brachytherapy and the Potential Value of Biodegradable Rectal Spacers  
  Schutzer, M., Orio, PF., Biagioli, M., Asher, D., Lomas, H., Moghanaki, D., Prostate Cancer Prostatic Dis, 1/1/2015
• Who Bears the Greatest Burden of Aggressive Treatment of Indolent Prostate Cancer?  
  Mahal, B, Cooperberg, M, Aizer, A, Ziehr, D, Hyatt, A, Choueiri, T, Hu, J, Sweeney, C, Beard, C, D'Amico, A, Martin, N, Orio, PF, Trinh, Q, Nguyen, P, Am J Med, 1/1/2015
• Incidence and determinants of 1-month mortality after cancer-directed surgery  
  Mahal BA, Inverso G, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hoffman KE, HU JC, Beard CJ, D'Amico AV, Martin NE, Orio PF 3rd, Trihn QD, Nguyen PL, Ann Oncol, 1/1/2015
• Use of a rectal space with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results  
  Mahal BA, Ziehr DR, Hyatt AS, Neubauer-Sugar EH, O'Farrell DA, O'Leary MP, Steele GS, Niedermayr TR, Beard CJ, Martin NE, Orio PF, D'Amico AV, Devlin PM, Nguyen PL, Brachytherapy, 1/1/2014
• Placement of empty catheters for an HDR-emulating LDR prostate brachytherapy technique: Comparison to standard intraoperative planning  
  Niedermayr TR, Nguyen PL, Murciano-Goroff YR, Kovtun KA, Neubauer Sugar E, Cail DW, O'Farrell DA, Hansen JL, Cormack RA, Buzurovic I, Wolfsberger LT, O'Leary MP, Steel..., Brachytherapy, 1/1/2014
• Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostate: Implication for the use of newer isotopes  
  Kovtun KA, Wolfsberger L, Niedermayr T, Sugar EN, Graham PL, Murciano-Goroff Y, Beard C, D'Amico AV, Martin NE, Orio PF, Nguyen PL, Brachytherapy, 1/1/2014
• High-Dose Rate brachytherapy for prostate cancer in a previously radiated patient with Polyethylene Glycol Hydrogel spacing to reduce rectal dose: Case report and revi...  
  Nguyen PL, Devlin PM, Beard CJ, Orio PF, O'Leary M, Wolfsberger L, O'Farrell, D, Hadaschik, BA, Hohenfellner M, Hatiboglu G, Brachytherapy, 1/1/2013
• Post-treatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality  
  Tseng YD, Chen MH, Beard CJ, Martin NE, Orio PF, Loffredo M, Renshaw AA, Choueiri TK, HU JC, Kantoff PW, D'Amico AV, Nguyen PL, J Urol, 1/1/2012
• Patient Reported Long-Term Rectal Function After Permanent Interstitial Brachytherapy for Localized Prostate Cancer  
  Orio PF, Butler WM, Merrick GS, Galbreath RW, Lief, W, Wallner, KE, Brachytherapy, 1/1/2012
• Low rate of clinical scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implication for prophylactic breast irradiation  
  Kishan AU, Chen MH, Loffredo M, Kim D, Beard CL, Hurwith MD, Martin NE, Orio PF, Kantoff PW, D'Amico AV, Nguyen PL, Pract Radiat Oncol, 1/1/2012
• 20 Gy vs 44 Gy supplemental external beam radiation with PD-103 for patients with greater risk disease: Results of a prospective randomized trial  
  Merrick GS, Wallner KE, Butler WM, Galbreath RW, Taira AV, Orio PF, Adamovick E, Int J Radiation Oncology Biol Phys, 1/1/2012
• External beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancer  
  Orio PF, Merrick G, Butler W, Brener S, Wallner KE, Allen Z, Kurko B, Galbreath R, Radiat Oncol, 1/22/2009
• The effects of the time interval between prostate brachytherapy and post-implant dosimetric evaluation in community practice: analysis of the Pro-Qura database  
  Orio PF, Grimm P, Merrick G, Blasko J, Sylvester J, Allen Z, Butler W, Chaudhry U, Am J Clin Oncol, 1/1/2008
• There is a wide range of predictive dosimetric factors for I-125 and Pd-103 prostate brachytherapy  
  Herstein A, Wallner K, Merrick GS, Orio PF, Thornton K, Butler W, Sutlief S, Am J Clin Oncol, 1/1/2008
• The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure  
  Bittner N, Wallner K, Merrick G, Orio PF, Nurani R, True L, Am J Clin Oncol, 1/1/2008
• The Prognostic Significance of Gleason Pattern 5 in Prostate Cancer Patients Treated With Pd-103 Brachytherapy  
  Mitsuyama, H, Wallner, K, Merrick, G, Virgin, J, Orio, PF, Montgomery, B, True, L, Am J Clin Oncol, 1/1/2007
• Intraoperative ultrasound-fluoroscopy fusion can enhance prostate brachytherapy quality  
  Orio PF, Tutar IB, Narayanan S, Authurs S, Cho P, Kim Y, Merrick G, Wallner K, Int. J. Radiat Oncol Biol Phys, 1/1/2007
• Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation  
  Orio PF, Wallner K, Merrick G, Herstein A, Mitsuyama P, Thornton K, Butler W, Int. J. Radiation Oncology Biol Phys, 1/1/2007
• 15 year Biochemical relapse free survival in clinical stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle Experience  
  Sylvester JE, Grimm PD, Blasko JC, Millar J, Orio PF, Skoglund S, Galbreath RW, Merrick G, Int. J. Radiat Oncol Biol Phys, 1/1/2007
• Join now to see all

Books/Book Chapters

• Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management 
  Chapter: Prognosis After Biochemical Failure for Localized Prostate Cancer: PSA and Beyond. 
  Page 269 - 276Orio, PF, Bittner, NEditors: Dicker, A, Kelly, W, Zaorsky, N, Trabulsi, E.2014

Abstracts/Posters

• 20 Gy vs 44 Gy supplemental external beam radiation with PD-103 for patients with higher risk disease: Results of a prospective randomized trial.
  Orio PF, American Brachytherapy Society Annual Meeting, San Diego, CA, 1/1/2011
• 20 Gy vs 44 Gy supplemental external beam radiation with PD-103 for patients with greater risk disease: Results of a prospective randomized trial.
  Merrick GS, Wallner KE, Butler WM, Galbreath RW, Taira AV, Orio PF (Presenter), Adamovick E, American Society for Radiation Oncology Annual Meeting, Miami, FL, 1/1/2011
• Long-term rectal function after permanent interstitial prostate brachytherapy.
  Orio PF, Butler WM, Merrick GS, Galbreath RW, Wallner KE, American Society for Radiation Oncology Annual Meeting, Miami, FL, 1/1/2011
• HDR-Emulating LDR Prostate (HELP) brachytherapy utilizing needle optimized inverse planned Intra-operative isotope delivery.
  Orio PF, Niedermayr TR, Wolfsberger LD, Kelly PJ, Cail D, Hansen J, Devlin PM, Nguyen PL, American Society for Radiation Oncology Annual Meeting, Miami, FL, 1/1/2011
• Seed-based Ultrasound and Fluoroscopy Registration using Iterative Optimal Assignment for Intraoperative Prostate Brachytherapy Dosimetry.
  Tutar I, Narayanan S, Lenz H, Nurani R, Orio PF, Cho P, Wallner K, Kim Y, Proc. SPIE, 1/1/2007
• Intraoperative TRUS-Fluoroscopy improves prostate brachytherapy quality.
  Orio PF, Wallner KE, Merrick GS, American Brachytherapy Society Annual Meeting, Chicago, IL, 1/1/2007
• Prognostic value of percentage of positive core biopsies in intermediate/high risk prostate cancer.
  Nurani RD, Wallner K, Merrick GM, Orio PF, Virgin J, True L, Journal of Clinical Oncology; ASCO Annual Meeting Proceedings, 1/20/2006
• Dosimetric Parameters as predictive factors for biochemical control in low risk prostate cancer patients treated with I-125 or PD-103 brachytherapy.
  Herstein A, Wallner K, Merrick G, Orio PF, True L, Butler W, Brachytherapy; American Brachytherapy Society Annual Meeting, Philadelphia, PA, May 10-12, 2006, 1/1/2006
• Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation.
  Orio PF, Wallner K, Merrick G, Herstein A, Mitsuyama P, Thornton K, Butler W, American Brachytherapy Society Annual Meeting, Philadelphia, PA, 1/1/2006
• Gamma Knife radiosurgery boost after neutron radiotherapy for salivary gland neoplasms.
  Orio PF, Douglas JG, Goodkin R, Stelzer, K, Laramore G, 13th International Meeting of the Leksell Gamma Knife Society, Seoul, Korea, 1/1/2006
• Comparison of treatment outcomes between Gamma Knife radiosurgery and Linac based radiosurgery in the treatment of arteriovenous malformations.
  Orio PF, Stelzer, K, Goodkin R, Douglas JG, 13th International Meeting of the Leksell Gamma Knife Society, Seoul, Korea, 1/1/2006
• 20 Gy versus 44 Gy Supplemental Beam Radiation with Pd-103 Prostate Brachytherapy: Early Biochemical Outcomes from a Prospective Randomized Multi-Center Trial.
  Orio PF, Wallner K, Merrick G, True L, Sutlief S, Butler W, Int J Radiat Oncol Biol Phys, 1/1/2005
• Treatment of thyroid gland neoplasm with fast neutron radiotherapy.
  Orio PF and Laramore GE, American Head and Neck Society Meeting, Boca Raton, FL, 1/1/2005
• Incidence and change over time of adverse isodose patterns in prostate brachytherapy.
  Reed DR, Wallner K , Narayanan S, Orio PF, Merrick G, Cho P, American Brachytherapy Society Annual Meeting, San Francisco, CA, 1/1/2005
• Join now to see all

Lectures

• Prostate Cancer Treatment: Where Does Brachytherapy Fit In 
  Cape Town, South Africa - 2017
• Prostate Cancer: Where Does Brachytherapy Fit In? 
  Boston, MA - 2017
• Can we really justify incorporating MRIs in Prostate Brachytherapy? 
  San Diego, CA - 2017
• A Primer on Payment: Why Defining Value in Brachytherapy is All Relative 
  Boston, MA - 2017
• Comparing Outcomes Effectiveness Research (CER) in Prostate Cancer Care 
  Boston, MA - 2017
• The Current Status of Individualized Care for Prostate Cancer 
  Attleboro, MA - 2017
• Dana-Farber/Brigham & Women’s Cancer Center and Milford Regional Medical Center Overview 
  Milford, MA - 2016
• Standard 4.6: Monitoring Compliance with Guidelines for 2015 Prostate Carcinoma Diagnoses 
  Weymouth, MA - 2016
• The Role of Hydrogel Spacer Technology in Radiation Treatment Delivery for Prostate Cancer 
  Boston, Ma - 2016
• Comparing Academic and Non-Academic Treatment Trends for Unfavorable Risk Localized Prostate Cancer: Are We Prepared to Boost Our Academic Standard? 
  San Francisco, CA - 2016
• Remembering Our Friend Peter Grimm: How the Seeds of Curiosity and Collaborations Changed an Industry 
  San Francisco, CA - 2016
• The Value of Brachytherapy for Prostate Cancer 
  Boston, MA - 2016
• Evolving Treatment Paradigms for High Risk Prostate Cancer: Prostatectomy versus Novel Dose-Escalation Techniques 
  Boston, MA - 2016
• Treatment Strategies for High-Risk Prostate Cancer 
  Tokyo, Japan - 2016
• Prostate Brachytherapy Utilization in the United States: Recent Declines and Corrective Strategies 
  Osaka, Japan - 2016
• The Status of Brachytherapy for Prostate Cancer: United States Perspective 
  Osaka, Japan - 2016
• "Is Supplemental External Bean Radiation Therapy Necessary for patients with Higher Risk Prostate Cancer Treated with PD-103? Results of Two Prospective Randomized Tri... 
  Orlando, FL - 1/1/2015
• "Cost Effectiveness of LDR and HDR Brachytherapy" 
  Orlando, FL - 1/1/2015
• "Pay Now or Pay Later: Introduction of the Value Scale" 
  Orlando, FL - 1/1/2015
• "Defining the Value Framework for Prostate Brachytherapy Using Patient-Centered Outcome Metrics and Time Driven Activity Based Costing" 
  Orlando, FL - 1/1/2015
• Prostate Brachytherapy: Seeding Quality and Cooperation Across Campuses 
  Boston, MA - 2015
• "Keynote Address: Adoption of surgery or radiotherapy for localized prostate cancer: brightness and darkness." 
  Yokohama, Japan - 1/1/2014
• "Recent Aspects and Future Prospects for Localized Prostate Cancer Treatments in the United States of America." 
  Yokohama, Japan - 1/1/2014
• "Comparison of Prostate Cancer Treatment Trends in the United States of America." 
  Hirosaki City, Japan - 1/1/2014
• "Interstitial Brachytherapy for Prostate Cancer: LDR and HDR, Alone and with External Beam Radiotherapy" 
  San Francisco, CA - 1/1/2014
• Join now to see all

Other

• "Paint It All Pink: Taking a 3-D Approach to Radiation" 
  Orio, III, PF, Local Newspaper
  1/1/2015
• "Radiation Oncology: A Road Map" 
  Orio, III, PF, DFCI/BWH Cancer Center
  Weymouth, MA - 1/1/2015
• "Understanding a Prostate Cancer Diagnosis" 
  Orio, III, PF, That Milford Show-Local Cable Television
  1/1/2015
• "Prostate Cancer Updates" 
  Orio, III, PF, The Phyllis Show-Local Cable Television
  1/1/2013
• "Prostate Cancer Screening" 
  Orio, III, PF, The Milford Show-Local Cable Television
  1/1/2011
• "Method of Testing the Performance of Laboratory Fume Hoods Using Carbon Dioxide and Video Exposure Monitoring" 
  Orio, III, PF, University of Massachusetts Library, Call LD3234.M268-1996.O695
  Amherst, MA - 1/1/1996
• ACR-ABS Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer. 
  Bittner, N, Orio, PF., Merrick, G., Prestidge, B., Hartford, A., Erickson-Wittmann, B., Desai, N., Gilbert, R., Ibbott, G., Loo, B., Mian, T., Michalski, J., Pope, C.,...
  http://www.acr.org/guidelines
• Join now to see all